<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016388"><a href="http://purl.obolibrary.org/obo/MONDO_0016388">MONDO:0016388</a></h3>
<p><strong>Label:</strong> bone sarcoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012817">MONDO:0012817</a> (Ewing sarcoma), <a href="http://purl.obolibrary.org/obo/MONDO_0009807">MONDO:0009807</a> (osteosarcoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0005164">MONDO:0005164</a> (fibrosarcoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0008977">MONDO:0008977</a> (chondrosarcoma (disease)),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_2677">Orphanet:2677</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2030">Orphanet:2030</a>, <a href="http://www.orpha.net/ORDO/Orphanet_668">Orphanet:668</a>, <a href="http://www.orpha.net/ORDO/Orphanet_319">Orphanet:319</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612219">OMIM:612219</a>, <a href="http://purl.obolibrary.org/obo/OMIM_215300">OMIM:215300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_117600">OMIM:117600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_259500">OMIM:259500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_55880">Orphanet:55880</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 44.58%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) 35.13%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000004">HP:0000004</a> (null))) 35.13%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000003">HP:0000003</a> (Multicystic kidney dysplasia))) 35.13%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) 31.98%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology) 31.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 29.62%</li>
<li>Thing 29.61%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 29.61%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology) 27.09%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 26.98%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 22.48%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology) 18.88%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system) 18.81%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 18.45%</li>
</ul>
</body>
</html>
